Design Therapeutics (DSGN) Q4 2025 Earnings

5NovConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-0.34
-0.31
-0.27
-0.24

Details

Expected EPS
-0.343333
Actual EPS
-0.3
Surprise EPS
0.04
Surprise Percent
+12.62%

Description

Design Therapeutics (DSGN) has reported earnings of -0.3 per share for Q4 2025.

0 Comments

Share your thoughts